SILO PHARMA, INC. Deferred Income Tax Expense (Benefit)
SILO PHARMA, INC. (SILO) reported Deferred Income Tax Expense (Benefit) of $0 for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2022-05-13
- SILO PHARMA, INC. deferred income tax expense (benefit) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- SILO PHARMA, INC. deferred income tax expense (benefit) for the quarter ending 2021-12-31 was $5.74K.
- SILO PHARMA, INC. deferred income tax expense (benefit) for the quarter ending 2021-03-31 was $24.88K.
- SILO PHARMA, INC. deferred income tax expense (benefit) for fiscal 2021 was $24.88K.
- SILO PHARMA, INC. deferred income tax expense (benefit) for fiscal 2020 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $5.74K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2021-12-31 | $5.74K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $24.88K 10-K · filed 2022-03-28 | ||
| 2021-09-30 | $19.13K 10-Q · filed 2021-11-10 | |||
| 2021-03-31 | $24.88K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |